Which scheme aims to develop India as a global hub for biologics and biosimilars?

  • A.National Biopharma Mission
  • B.BioE3 Policy
  • C.Biopharma SHAKTI
  • D.PLI Scheme for Pharmaceuticals

Detailed Solution:

Correct Answer: Biopharma SHAKTI

Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology and Innovation), announced in the Union Budget 2026-27, is a ₹10,000 crore, five-year initiative to transform India into a leading global biopharma hub.

It focuses on strengthening domestic production of biologics and biosimilars, building an end-to-end ecosystem with new/upgraded NIPER institutes, 1,000+ clinical trial sites, and enhanced regulatory capacity to capture 5% of the global biopharmaceutical market, reduce import dependence, and boost competitiveness in high-value biologics supply chains.

Next Q&A